PUBLISHER: The Business Research Company | PRODUCT CODE: 1945358
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945358
An implantable pulse generator (IPG) is a medical device used to deliver electrical impulses to specific nerves or muscles within the body. It is commonly employed in neuromodulation therapies to manage conditions such as chronic pain or movement disorders. The IPG is surgically implanted under the skin and can be programmed to adjust stimulation levels as required.
The primary types of implantable pulse generators include implantable cardiac pacemakers, implantable defibrillators, cochlear implants, implantable nerve stimulators (functional electrical stimulation or FES), implantable infusion pumps, and implantable active monitoring devices. Implantable cardiac pacemakers, for example, are devices placed in the chest to regulate abnormal heart rhythms by delivering electrical impulses to stimulate the heart. They come in rechargeable and non-rechargeable variants and are used for cardiovascular diseases, movement disorders, orthopedic conditions, and other health issues. End users of these devices include hospitals, ambulatory surgical centers, home care settings, and clinics.
Tariffs have introduced supply chain disruptions and cost pressures in the implantable pulse generator market by increasing import duties on electronic components, batteries, and precision medical-grade materials. These impacts have raised manufacturing costs and affected pricing across rechargeable and non rechargeable devices, with north america and asia-pacific regions being most impacted due to globalized sourcing dependencies. Hospitals and ambulatory surgical centers have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. On the positive side, tariffs have encouraged domestic manufacturing investments, supplier diversification, and localized production strategies, improving long-term supply chain resilience.
The implantable pulse generator market research report is one of a series of new reports from The Business Research Company that provides implantable pulse generator market statistics, including implantable pulse generator industry global market size, regional shares, competitors with a implantable pulse generator market share, detailed implantable pulse generator market segments, market trends and opportunities, and any further data you may need to thrive in the implantable pulse generator industry. This implantable pulse generator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable pulse generator market size has grown rapidly in recent years. It will grow from $147.01 billion in 2025 to $162.9 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, increasing incidence of cardiovascular diseases, growing adoption of implantable medical devices, expansion of hospital-based surgical procedures, rising awareness of neuromodulation therapies.
The implantable pulse generator market size is expected to see rapid growth in the next few years. It will grow to $245.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, growing aging population, rising burden of neurological disorders, expanding access to advanced implantable therapies, increasing focus on long-term disease management. Major trends in the forecast period include growing adoption of neuromodulation therapies, rising use of implantable pulse generators for chronic pain management, increasing preference for rechargeable implantable pulse generators, expansion of implantable pulse generator applications in movement disorders, growing demand for long-term implantable stimulation devices.
The increasing prevalence of neurological disorders is expected to drive the growth of the implantable pulse generator market. Neurological disorders affect the brain, spinal cord, and nervous system, impacting movement, sensation, and cognition. The rise in these disorders is linked to factors such as an aging population, lifestyle changes, environmental influences, and advancements in diagnostic techniques. Implantable pulse generators assist in managing neurological disorders by delivering targeted electrical impulses to modulate abnormal neural activity and alleviate symptoms. For example, in October 2023, the World Federation of Neurology, a UK-based non-profit organization, reported that over 40% of the global population currently experiences a neurological condition, and this burden is projected to nearly double in the coming years. Thus, the growing incidence of neurological disorders is fueling the expansion of the implantable pulse generator market.
Major companies in the implantable pulse generator (IPG) market are focusing on MRI-conditional neurostimulators, including sensing-enabled rechargeable IPGs, to strengthen their competitive position. For example, in April 2024, Medtronic, a US-based healthcare company, received FDA approval for its Inceptiv closed-loop spinal cord stimulator, which monitors evoked compound action potentials (ECAPs) 50 times per second to adjust stimulation in real time while permitting full-body 1.5 T and 3 T MRI scans. Similarly, in January 2024, Medtronic launched the Percept RC rechargeable deep brain stimulation neurostimulator, equipped with BrainSense sensing technology, a 15-year battery life, and full-body MRI compatibility at 1.5 T and 3 T with therapy active. These innovations improve therapy personalization and patient safety, although they may involve higher development and device costs.
In October 2025, Boston Scientific Corporation, a US-based health technology company, acquired Nalu Medical, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific aims to expand and strengthen its neuromodulation portfolio for chronic pain management. Nalu Medical, Inc. is a US-based medical equipment manufacturer specializing in implantable pulse generators.
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Nevro Corp, LivaNova PLC, NeuroPace Inc, NeuroSigma Inc, Saluda Medical Pty Ltd, Synapse Biomedical Inc, Nuvectra Medical Inc, MainStay Medical International PLC, Aleva Neurotherapeutics SA, Bioness Inc, EnteroMedics Inc, Neuronetics Inc, Axonics Inc, Sceneray Co Ltd, Cirtec Medical, BlueWind Medical, Syntach AB, Osaka Medical Devices, Gimer Medical, Saluda Medical
North America was the largest region in the implantable pulse generator market in 2025. The regions covered in the implantable pulse generator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable pulse generator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The implantable pulse generator market consists of sales of neurostimulators, sacral nerve stimulators, and deep brain stimulation (DBS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Pulse Generator Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable pulse generator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable pulse generator ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable pulse generator market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.